InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Gaston-Dreyfus Remi, Director. Officer active across 1 company, notably Bionik Laboratories Corp.. Cumulatively, 6 reports have been logged. Breakdown: 2 buys · 0 sell. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Gaston-Dreyfus Remi is Administrateur at Bionik Laboratories Corp. on the XNAS market. He has filed 6 disclosures in total, and among the sampled recent filings, the period runs from 2021-12-13 to 2023-06-21, with the transaction nature indicated as Acquisition.